These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 23676198)
41. A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department. Larkin GL; Beautrais AL Int J Neuropsychopharmacol; 2011 Sep; 14(8):1127-31. PubMed ID: 21557878 [TBL] [Abstract][Full Text] [Related]
42. Trajectory in obsessive-compulsive disorder comorbidities. de Mathis MA; Diniz JB; Hounie AG; Shavitt RG; Fossaluza V; Ferrão Y; Leckman JF; de Bragança Pereira C; do Rosario MC; Miguel EC Eur Neuropsychopharmacol; 2013 Jul; 23(7):594-601. PubMed ID: 22921470 [TBL] [Abstract][Full Text] [Related]
43. Intranasal Ketamine and Cognitive-Behavioral Therapy for Treatment-Refractory Obsessive-Compulsive Disorder. Adams TG; Bloch MH; Pittenger C J Clin Psychopharmacol; 2017 Apr; 37(2):269-271. PubMed ID: 28121735 [No Abstract] [Full Text] [Related]
44. Urgent ketamine infusion rapidly eliminated suicidal ideation for a patient with major depressive disorder: a case report. Zigman D; Blier P J Clin Psychopharmacol; 2013 Apr; 33(2):270-2. PubMed ID: 23422387 [No Abstract] [Full Text] [Related]
46. Lifetime comorbidity of obsessive-compulsive disorder and sub-threshold obsessive-compulsive symptomatology in the community: impact, prevalence, socio-demographic and clinical characteristics. Fineberg NA; Hengartner MP; Bergbaum C; Gale T; Rössler W; Angst J Int J Psychiatry Clin Pract; 2013 Aug; 17(3):188-96. PubMed ID: 23428236 [TBL] [Abstract][Full Text] [Related]
47. Obsessive-compulsive syndromes and disorders: significance of comorbidity with bipolar and anxiety syndromes. Angst J; Gamma A; Endrass J; Hantouche E; Goodwin R; Ajdacic V; Eich D; Rössler W Eur Arch Psychiatry Clin Neurosci; 2005 Feb; 255(1):65-71. PubMed ID: 15711895 [TBL] [Abstract][Full Text] [Related]
48. [Bipolar obsessive-compulsive disorder: confirmation of results of the "ABC-OCD" survey in 2 populations of patient members versus non-members of an association]. Hantouche EG; Kochman F; Demonfaucon C; Barrot I; Millet B; Lancrenon S; Akiskal HS Encephale; 2002; 28(1):21-8. PubMed ID: 11963340 [TBL] [Abstract][Full Text] [Related]
49. Fluoxetine treatment of depressed patients with comorbid anxiety disorders. Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627 [TBL] [Abstract][Full Text] [Related]
50. Ketamine for acute suicidal ideation. An emergency department intervention: A randomized, double-blind, placebo-controlled, proof-of-concept trial. Domany Y; Shelton RC; McCullumsmith CB Depress Anxiety; 2020 Mar; 37(3):224-233. PubMed ID: 31733088 [TBL] [Abstract][Full Text] [Related]
51. Obsessive-compulsive symptoms in major depressive disorder correlate with clinical severity and mixed features. Olgiati P; Fanelli G; Serretti A Int Clin Psychopharmacol; 2022 Jul; 37(4):166-172. PubMed ID: 35191860 [TBL] [Abstract][Full Text] [Related]
52. Anxiety and major depression comorbidity in a family study of obsessive-compulsive disorder. Carter AS; Pollock RA; Suvak MK; Pauls DL Depress Anxiety; 2004; 20(4):165-74. PubMed ID: 15643633 [TBL] [Abstract][Full Text] [Related]
53. Correlates and impact of obsessive-compulsive comorbidity in bipolar disorder. Magalhães PV; Kapczinski NS; Kapczinski F Compr Psychiatry; 2010; 51(4):353-6. PubMed ID: 20579506 [TBL] [Abstract][Full Text] [Related]
54. The association between obsessive compulsive disorder and obsessive compulsive personality disorder: prevalence and clinical presentation. Gordon OM; Salkovskis PM; Oldfield VB; Carter N Br J Clin Psychol; 2013 Sep; 52(3):300-15. PubMed ID: 23865406 [TBL] [Abstract][Full Text] [Related]
55. Obsessive-compulsive disorder with and without bipolar disorder. Mahasuar R; Janardhan Reddy YC; Math SB Psychiatry Clin Neurosci; 2011 Aug; 65(5):423-33. PubMed ID: 21851451 [TBL] [Abstract][Full Text] [Related]
56. Suicidal ideation in patients with obsessive-compulsive disorder. Balci V; Sevincok L Psychiatry Res; 2010 Jan; 175(1-2):104-8. PubMed ID: 19923009 [TBL] [Abstract][Full Text] [Related]
57. Clinical correlates of recurrent major depression in obsessive-compulsive disorder. Hong JP; Samuels J; Bienvenu OJ; Cannistraro P; Grados M; Riddle MA; Liang KY; Cullen B; Hoehn-Saric R; Nestadt G Depress Anxiety; 2004; 20(2):86-91. PubMed ID: 15390212 [TBL] [Abstract][Full Text] [Related]
58. Dose-response relationship between number of comorbid anxiety disorders in adolescent bipolar/unipolar disorders, and psychosis, suicidality, substance abuse and familiality. Dilsaver SC; Akiskal HS; Akiskal KK; Benazzi F J Affect Disord; 2006 Dec; 96(3):249-58. PubMed ID: 16904187 [TBL] [Abstract][Full Text] [Related]
59. A Systematic Review of Neurocognitive Effects of Subanesthetic Doses of Intravenous Ketamine in Major Depressive Disorder, Post-Traumatic Stress Disorder, and Healthy Population. Shiroma PR; Velit-Salazar MR; Vorobyov Y Clin Drug Investig; 2022 Jul; 42(7):549-566. PubMed ID: 35672558 [TBL] [Abstract][Full Text] [Related]
60. Current Status of Ketamine and Related Therapies for Mood and Anxiety Disorders. Costi S; Van Dam NT; Murrough JW Curr Behav Neurosci Rep; 2015 Dec; 2(4):216-225. PubMed ID: 26783510 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]